Ulrika Svenson

TL;DR: It is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases, as well as single nucleotide polymorphisms (SNPs) that are strongly associated with telomere length in the general population.

TL;DR: The results of this meta-analysis suggest that the presence of shortened telomeres may be a marker for susceptibility to human cancer, but single larger, well-design prospective studies are warranted to confirm these findings.

TL;DR: The results indicate that blood RTL may serve as a prognostic indicator in breast cancer patients with advanced disease, and relative telomere length of peripheral blood cells in relation to breast cancer incidence and prognosis.

TL;DR: There was no association between individual telomere attrition rate or prediagnostic TL and later tumor development, and the collected data strongly suggest a TL maintenance mechanism acting in vivo, providing protection of short telomeres as previously demonstrated in vitro.

TL;DR: Intra- and inter-laboratory technical variation severely limits the usefulness of data pooling and excludes sharing of reference ranges between laboratories, and it is proposed to establish a common set of physical telomere length standards to improve comparability of telomeres length estimates between laboratories.